Herombopag ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
60	Aplastic anemia	1
63	Idiopathic thrombocytopenic purpura	1

60. Aplastic anemia

---

Clinical trials : 245 /  Drugs : 318 - (DrugBank : 86) / Drug target genes : 44 - Drug target pathways : 166

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05660785 (ClinicalTrials.gov)	December 1, 2022	23/11/2022	Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia	The Efficacy and Safety of Herombopag Combined With Cyclosporine for Patients With Non Severe Aplastic Anemia	Non Severe Aplastic Anemia;Untreated	Drug: Herombopag	Institute of Hematology & Blood Diseases Hospital	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	Recruiting	18 Years	N/A	All	54	Phase 2	China

63. Idiopathic thrombocytopenic purpura

---

Clinical trials : 391 /  Drugs : 235 - (DrugBank : 50) / Drug target genes : 49 - Drug target pathways : 139

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05685420 (ClinicalTrials.gov)	January 23, 2023	6/1/2023	Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia	Extension Study of Herombopag in Children and Adolescents With Chronic Primary Immune Thrombocytopenia	Immune Thrombocytopenia	Drug: Herombopag	Jiangsu HengRui Medicine Co., Ltd.	NULL	Not yet recruiting	6 Years	17 Years	All	117	Phase 3	NULL